Orange Book product · Brand (NDA)
PARAFLEX
CHLORZOXAZONE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CHLORZOXAZONE
Strength
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 011300
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1987PARAFON FORTE DSCBrand (NDA)
NDA 011529 · JANSSEN R AND D
- 2024CHLORZOXAZONEGeneric (ANDA)
ANDA 210961 · SENORES PHARMS
- 2023CHLORZOXAZONEGeneric (ANDA)
ANDA 089853 · AUROBINDO PHARMA LTD
- 2023CHLORZOXAZONEGeneric (ANDA)
ANDA 216925 · RISING
- 2023CHLORZOXAZONEGeneric (ANDA)
ANDA 214365 · ACME LABS
- 2023CHLORZOXAZONEGeneric (ANDA)
ANDA 214702 · COREPHARMA
- 2023CHLORZOXAZONEGeneric (ANDA)
ANDA 212047 · SOMERSET THERAPS LLC
- 2023CHLORZOXAZONEGeneric (ANDA)
ANDA 215540 · AJENAT PHARMS
- 2022CHLORZOXAZONEGeneric (ANDA)
ANDA 214941 · COREPHARMA
- 2022CHLORZOXAZONEGeneric (ANDA)
ANDA 213126 · RISING
- 2021CHLORZOXAZONEGeneric (ANDA)
ANDA 215158 · SENORES PHARMS
- 2021CHLORZOXAZONEGeneric (ANDA)
ANDA 212743 · PH HEALTH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
